Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review
Arch Bronconeumol. 2024 Jan;60(1):55-58.
doi: 10.1016/j.arbres.2023.10.006.
Epub 2023 Oct 30.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Neumología, Hospital San Pedro de Alcántara, Ciberes, Cáceres, Spain. Electronic address: jantonio.riesco@gmail.com.
- 2 Servicio de Neumología, Hospital Universitario Clínico San Carlos, Madrid, Spain.
- 3 Servicio de Neumología y Cirugía Torácica, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.
- 4 Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Sevilla, Spain.
- 5 Centro de salud Menasalbas, Menasalbas, Toledo, Spain.
- 6 Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard University Medical School, Boston, MA, USA.
No abstract available
Publication types
-
Comparative Study
-
Systematic Review
MeSH terms
-
Administration, Inhalation
-
Adrenal Cortex Hormones / therapeutic use
-
Adrenergic beta-2 Receptor Agonists / therapeutic use
-
Bronchodilator Agents* / therapeutic use
-
Drug Therapy, Combination
-
Humans
-
Muscarinic Antagonists / therapeutic use
-
Nebulizers and Vaporizers
-
Pulmonary Disease, Chronic Obstructive* / drug therapy
-
Treatment Outcome
Substances
-
Adrenal Cortex Hormones
-
Adrenergic beta-2 Receptor Agonists
-
Bronchodilator Agents
-
Muscarinic Antagonists